|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01160024
|
methoxy mycolic acid
|
2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid
|
FA 83:1;O2
|
C83H164O4
|
1225.262963
|
|
LMFA07010716
|
2-Hexenoylcholine
|
{2-[(2E)-hex-2-enoyloxy]ethyl}trimethylazanium
|
|
C11H22NO2
|
200.165054
|
|
LMFA07070027
|
(9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine
|
3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 18:3;O
|
C25H43NO5
|
437.314124
|
|
LMFA07070027
|
(9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine
|
3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 18:3;O
|
C25H43NO5
|
437.314124
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA01030982
|
4-ene-Valproic acid
|
2-propylpent-4-enoic acid
|
FA 8:1
|
C8H14O2
|
142.099380
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|
|
LMFA07050100
|
(1-hydroxycyclohexyl)acetyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 8:1;O
|
C29H48N7O18P3S
|
907.198939
|
|
LMFA01031125
|
5Z,9Z,21Z-hexacosatrienoic acid
|
5Z,9Z,21Z-hexacosatrienoic acid
|
FA 26:3
|
C26H46O2
|
390.349781
|
|
LMFA07050176
|
2E-Dodecenoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 12:1
|
C33H56N7O17P3S
|
947.266624
|
|
LMFA07050176
|
2E-Dodecenoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 12:1
|
C33H56N7O17P3S
|
947.266624
|
|
LMFA07050176
|
2E-Dodecenoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 12:1
|
C33H56N7O17P3S
|
947.266624
|
|
LMFA07050176
|
2E-Dodecenoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 12:1
|
C33H56N7O17P3S
|
947.266624
|
|
LMFA07050176
|
2E-Dodecenoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 12:1
|
C33H56N7O17P3S
|
947.266624
|
|
LMFA02000328
|
9Z,11Z,13Z,15Z-octadecatetraenoic acid
|
9Z,11Z,13Z,15Z-octadecatetraenoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA01030091
|
22-tricosenoic acid
|
22-tricosenoic acid
|
FA 23:1
|
C23H44O2
|
352.334131
|
|
LMFA01050168
|
12-hydroxy-10-dodecenoic acid
|
12-hydroxy-10-dodecenoic acid
|
FA 12:1;O
|
C12H22O3
|
214.156895
|
|
LMFA01050168
|
12-hydroxy-10-dodecenoic acid
|
12-hydroxy-10-dodecenoic acid
|
FA 12:1;O
|
C12H22O3
|
214.156895
|
|
LMFA01031052
|
Methyl 7Z,11Z-Hexadecadienoate
|
Methyl 7Z,11Z-Hexadecadienoate
|
FA 17:2
|
C17H30O2
|
266.224581
|
|
LMFA01050550
|
3-Acetoxy-palmitic acid
|
3-Acetoxy-hexadecanoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA01031060
|
9Z,11Z,14Z-Eicosatrienoic acid
|
9Z,11Z,14Z-Eicosatrienoic acid
|
FA 20:3
|
C20H34O2
|
306.255881
|
|
LMFA01031057
|
3Z,5E,7E-Decatrienoic acid
|
3Z,5E,7E-Decatrienoic acid
|
FA 10:3
|
C10H14O2
|
166.099380
|
|
LMFA01031048
|
9,11,13-Octadecatriynoic acid
|
Octadecatri-9,11,13-ynoic acid
|
FA 18:6
|
C18H24O2
|
272.177630
|
|
LMFA01170147
|
Asperitaconic acid B
|
9-acetoxy-3S-carboxy-2-methylidenenonanoic acid
|
FA 13:3;O4
|
C13H20O6
|
272.125990
|
|
LMFA01031366
|
Euphormarginata acid A
|
10Z,12Z,15Z-octadecatrienoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA08020211
|
Linoleyl hydroxamic acid
|
N-hydroxy-9Z,12Z-octadecadienamide
|
NA 18:2;O
|
C18H33NO2
|
295.251129
|
|
LMFA01160028
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
FA 57:1;O
|
C57H112O3
|
844.861147
|
|
LMFA01160028
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
FA 57:1;O
|
C57H112O3
|
844.861147
|
|
LMFA01160028
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid
|
FA 57:1;O
|
C57H112O3
|
844.861147
|
|
LMFA01160053
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 71:0;O2
|
C71H142O4
|
1059.090812
|
|
LMFA01160053
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 71:0;O2
|
C71H142O4
|
1059.090812
|
|
LMFA01160053
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 71:0;O2
|
C71H142O4
|
1059.090812
|
|
LMFA01160053
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid
|
FA 71:0;O2
|
C71H142O4
|
1059.090812
|
|
LMFA01031137
|
Octadeca-9-en-12,14,16-triynoic acid
|
(Z)-octadeca-9-en-12,14,16-triynoic acid
|
FA 18:7
|
C18H22O2
|
270.161980
|
|
LMFA08020224
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
|
C38H70N2O7
|
666.518304
|
|
LMFA08020224
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
|
C38H70N2O7
|
666.518304
|
|
LMFA08020224
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester
|
|
C38H70N2O7
|
666.518304
|
|
LMFA08020208
|
(2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide
|
N-isobutylundeca-2E,4E-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA08020208
|
(2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide
|
N-isobutylundeca-2E,4E-dien-8,10-diynamide
|
NA 15:6
|
C15H19NO
|
229.146664
|
|
LMFA01160092
|
2-tetracosyl-3-hydroxy-40-oxo-41-methyl-heptapentacontanoic acid
|
2-tetracosyl-3-hydroxy-40-oxo-41-methyl-heptapentacontanoic acid
|
FA 82:1;O2
|
C82H162O4
|
1211.247313
|
|
LMFA01050567
|
3R-hydroxymyristic acid methyl ester
|
Methyl 3R-hydroxytetradecanoate
|
FA 15:0;O
|
C15H30O3
|
258.219496
|
|
LMFA01010019
|
Nonadecylic acid
|
nonadecanoic acid
|
FA 19:0
|
C19H38O2
|
298.287181
|
|
LMFA03040014
|
Lipoxin B5
|
5S,14R,15S-trihydroxyicosa-6E,8Z,10E,12E,17Z-pentaenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03040014
|
Lipoxin B5
|
5S,14R,15S-trihydroxyicosa-6E,8Z,10E,12E,17Z-pentaenoic acid
|
FA 20:5;O3
|
C20H30O5
|
350.209326
|
|
LMFA03120004
|
clavulone IV
|
methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
FA 25:8;O5
|
C25H34O7
|
446.230456
|
|
LMFA03120004
|
clavulone IV
|
methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
FA 25:8;O5
|
C25H34O7
|
446.230456
|
|
LMFA03120004
|
clavulone IV
|
methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12]
|
FA 25:8;O5
|
C25H34O7
|
446.230456
|